Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy
The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Voltage-gated sodium channels (Na(V)) are critical for initiation of action potentials. Heterozygous loss-of-function mutations in Na(V)1.1 channels cause severe myoclonic epilepsy in infancy (SMEI). Homozygous null Scn1a-/- mice developed ataxia and died on postnatal day (P) 15 but could be sustained to P17.5 with manual feeding. Heterozygous Scn1a+/- mice had spontaneous seizures and sporadic deaths beginning after P21, with a notable dependence on genetic background. Loss of Na(V)1.1 did not change voltage-dependent activation or inactivation of sodium channels in hippocampal neurons. The sodium current density was, however, substantially reduced in inhibitory interneurons of Scn1a+/- and Scn1a-/- mice but not in their excitatory pyramidal neurons. An immunocytochemical survey also showed a specific upregulation of Na(V)1.3 channels in a subset of hippocampal interneurons. Our results indicate that reduced sodium currents in GABAergic inhibitory interneurons in Scn1a+/- heterozygotes may cause the hyperexcitability that leads to epilepsy in patients with SMEI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, a dominant loss of function mutation in Nav1.1 causes Dravet syndrome, an intractable form of childhood-onset epilepsy that arises from a reduction in Na+ channel density in hippocampal interneurons (1255).”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [1255]
In the citing paper
“Haploinsufficiency or pathogenic variants of Scn1a cause Dravet Syndrome, a common and intractable form of epileptic encephalopathy characterized by the early onset of seizures17–19.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [19]
In the citing paper
“As loss of expression of Scn1a is especially associated with PV cIN disfunction15–19”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [19]
Citations
Cites
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329 · cited 1×
“The targeting construct was linearized at the Not I site in the polylinker and was electroporated into R1 embryonic stem cell”
MethodEngel, J. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.10401.x · Cited by 2,251
From Ionic Currents to Molecular Mechanisms
Catterall, W. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81133-2 · Cited by 2,118 · cited 1×
“dtd" [ ]> Voltage-gated Na + channels in the brain are complexes of a 260-kDa α-subunit in association with auxiliary β-subunits (β1–β4) of 33 to 36 kD”
Self-citationEpileptic Syndromes in Infancy, Childhood and Adolescence
Rogers, J., Bureau, M., Dravet, C., Dreifuss, F. E., Perret, A., Wolf, P., & Armstrong, D. L. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199307000-00012 · Cited by 1,470
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292
(2005) · Cited by 944
Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy
de Lanerolle, N. C., Kim, J. H., Robbins, R. J., & Spencer, D. D. (1989) · Brain Research · doi:10.1016/0006-8993(89)90234-5 · Cited by 927
Buhl, E. H., Halasy, K., & Somogyi, P. (1994) · Nature · doi:10.1038/368823a0 · Cited by 728
Overview of the voltage-gated sodium channel family
Yu (2003) · Genome biology · doi:10.1186/gb-2003-4-3-207 · Cited by 694 · cited 1×
“dtd" [ ]> Voltage-gated Na + channels in the brain are complexes of a 260-kDa α-subunit in association with auxiliary β-subunits (β1–β4) of 33 to 36 kD”
Sodium channel Na v 1.6 is localized at nodes of Ranvier, dendrites, and synapses
Caldwell, J. H., Schaller, K. L., Lasher, R. S., Peles, E., & Levinson, S. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090034797 · Cited by 649 · cited 1×
“6 is localized in dendrites and in the nodes of Ranvie”
Background
Cited by
Items 801–900 of 1,000
Isom, L. L. (2014) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7597-14.6.350 · Cited by 5
Zhang, Y., Lp, Z., Ding, Y.-X., He, B., & Yang, G. (2014) · PubMed · Cited by 6
Cellular bases of focal and generalized epilepsies
Schwartzkroin, P. A. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52898-8.00002-1 · Cited by 7
Spike ripples in striatum correlate with seizure risk in two mouse models
Shi, W., Zemel, D., Sridhar, S., Mount, R. A., Richardson, R. M., Eden, U. T., Han, X., Kramer, M., & Chu, C. J. (2022) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2022.100529 · Cited by 5
“In rodent models of seizures and epilepsy, interictal spikes [10,11], physiologic and pathologic ripples [12,13], and the co-occurrence of these events have been reported [14–16].”
BackgroundWang, S., Yu, Y., Wang, X., Deng, X., Ma, J., Liu, Z., Gu, W., & Sun, D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.950255 · Cited by 5
Structure-function relationship of new peptides activating human Nav1.1
Lopez, L., Waard, S. D., Meudal, H., Caumes, C., Khakh, K., Peigneur, S., Oliveira-Mendes, B. B. R., Lin, S., Waele, J. D., Montnach, J., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115173 · Cited by 6
Self-citationSugiura, Y., & Ugawa, Y. (2016) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-000963 · Cited by 5
Clinical and genetic characteristics and diagnosis of hereditary variants of neonatal epilepsy
Semenova, N. A., Леонидовна, Д. Е., Sharkov, A. A., & Акимова, И. А. (2017) · Neuromuscular Diseases · doi:10.17650/2222-8721-2017-7-3-36-42 · Cited by 5
“Сегодня известно более 50 моногенных вариантов этой группы заболеваний [17, 18], большинство из которых являются каналопатиями, связанными с нарушением функции ионных (натриевых и калиевых) и лигандзависимых (гамма-аминомасляная кислота) каналов нейронов коры головного мозга [19].”
Mutations of Ion Channels in Genetic Epilepsies
Mantegazza, M., Rusconi, R., & Cestèle, S. (2014) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-12283-0_2 · Cited by 5
“…impairment and reduction of Na+ current selectively in GABAergic inhibitory interneurons, causing reduction of their excitability and of GABAergic inhibition, leading to network hyperexcitability (Yu et al. 2006; Ogiwara et al. 2007; Han et al. 2012; Ito et al. 2012; Liautard et al. 2013).”
BackgroundSelf-citationGenetics of the epilepsies: Channelopathies and beyond
Scheffer, I. E. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02934.x · Cited by 5
“that excitingly recapitulate the human phenotype, shown in a c-aminobutyric acid (GABA) subunit mutation of typical childhood absence epilepsy and in SCN1A models of Dravet syndrome (Yu et al., 2006; Tan et al., 2007).”
BackgroundDravet syndrome: Not just epilepsy
Guerrini, R., & Striano, P. (2016) · Neurology · doi:10.1212/wnl.0000000000002873 · Cited by 5
Diaz-Arce, D., Ghouma, A., Scalmani, P., Mantegazza, M., & Duprat, F. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.15.488472 · Cited by 6
“Heterozygous knock-out Scn1a (Scn1a +/- ) mice are an established model of Dravet syndrome (Yu, Mantegazza et al. 2006, Liautard, Scalmani et al. 2013, Mantegazza and Broccoli 2019, Mantegazza, Cestele et al. 2021) they were in the C57Bl/6J background and were recorded (video) between P21 and P40.”
BackgroundInfluentialSelf-citationAxonopathy and altered synaptic development in early hippocampal epileptogenesis of Dravet syndromePreprint
Layer, N., Müller, P., Ayash, M., Pfeiffer, F., Saile, M., Klopfer, F., Iavarone, S., Santuy, A., Fallier‐Becker, P., Hedrich, U. B. S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.04.560735 · Cited by 6
Hawkins, N. A., Speakes, N., & Kearney, J. A. (2024) · Mammalian Genome · doi:10.1007/s00335-024-10046-3 · Cited by 4
“A consistent feature among Dravet mouse models is variable penetrance and expressivity of Dravet-like phenotypes dependent on genetic strain background (Miller et al. 2014; Rubinstein et al. 2015; Yu et al. 2006).”
BackgroundInfluentialJi, J., Zhou, X., Lu, Y., Shen, L., Li, L., Chen, Z., Shi, Y., Liao, W., & Yu, L. (2024) · Gene · doi:10.1016/j.gene.2024.148876 · Cited by 4
Yang, Y., Cai, Y., Wang, S., Wu, X., Shao, Z., Wang, X., & Ding, J. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01429-w · Cited by 5
“In addition, the distribution of ion channels on excitatory and inhibitory neurons is different, which may lead to a bias in our assessment of drug efficacy [36].”
Emerging Insights into the Pathogenic Mechanisms of Dravet Syndrome
Tonesi, N., Berselli, E., Abid, S. B., Puja, G., & Losi, G. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04471-2 · Cited by 4
Interneurons, GABAA signaling and their presumptive role in catamenial epilepsy
Li, F. R., Wang, S., Suarez, C. F., Lévesque, M., & Avoli, M. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106291 · Cited by 8
Turpín, I., Modrego, A., Martí-Sarrias, A., García‐González, L., Ortega-Gascó, A., Haeb, A.-C., Pareja, R. I., Soriano, J., Ruíz, N., Peñuelas‐Haro, I., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113831 · Cited by 10
“20,21 Other severe DEEs have been successfully modeled using brain organoids, such as Rett Syndrome, where epileptogenic currents were observed compared to isogenic cell lines.”
cGAS-mediated type I IFN signaling contributes to disease progression in drug-refractory epilepsy
Huang, Y., Fan, L., Wong, M. Y., Lei, Z., Krishnamachary, B., Zhu, D., Cadiz, M. P., Nagiri, R. K., Ye, P., Norman, K., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02384-z · Cited by 5
“To assess whether cGAS reduction could mitigate the worsened epileptic phenotypes of Scn1a +/− mice on the B6 background 28,31 , we backcrossed Scn1a +/− 129S6 mice with Cgas −/− or Cgas +/+ B6 mice for three generations (Extended Data Fig.”
Westenbroek, R. E., Kaplan, J. S., Viray, K., & Stella, N. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106099 · Cited by 8
Self-citationSpecchio, N., & Auvin, S. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110271 · Cited by 5
Aboutorabi, A., Naderi, N., Pourbadie, H. G., Zolfagharian, H., & Vatanpour, H. (2018) · PubMed Central · Cited by 4
Anderson, L. L., Bahceci, D., Hawkins, N. A., Everett‐Morgan, D., Banister, S. D., Kearney, J. A., & Arnold, J. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280842 · Cited by 4
“Heterozygous deletion of Scn1a (Scn1a) in mice reproduces the core clinical features of Dravet syndrome, including hyperthermia-induced seizures, spontaneous seizures and poor survival [21,22].”
BackgroundNeurodevelopmental disorders: 2023 update
Carriba, P., Lorenzón, N., & Dierssen, M. (2023) · Free Neuropathology · doi:10.17879/freeneuropathology-2023-4701 · Cited by 5
“1 channels during early life (Yu et al., 2006), so that SCN1A loss of function leads to postnatal epilepsy, which disappears in adulthood (Favero et al., 2018).”
BackgroundNakakubo, S., Hiramatsu, Y., Goto, T., Kimura, S., Narugami, M., Nakajima, M., Ueda, Y., Shiraishi, H., Manabe, A., Sharmin, D., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1273633 · Cited by 4
“…to WT, which could re fl ect compensatory plasticity mechanism (Luscher et al., 2011) resulting from pre-synaptic dysfunctions as shown by decreased sIPSC frequency (Figure 3B) (Yu et al., 2006; Han et al., 2012; Beretta et al., 2022) or by impairment of PV + neuron fi ring (Ogiwara et al., 2007).”
BackgroundThe Dawn and Advancement of the Knowledge of the Genetics of Migraine
Zalaquett, N., Salameh, E., Kim, J. M., Ghanbarian, E., Tawk, K., & Abouzari, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092701 · Cited by 5
Caldart, C. S., Sanchez, R. E. A., Ben‐Hamo, M., Beck, A. I., Weil, T. A., Perez, J. G., Kalume, F., Brunton, B. W., & de la Iglesia, H. O. (2025) · Journal of Biological Rhythms · doi:10.1177/07487304251336649 · Cited by 4
“…which model an intractable form of epilepsy called Dravet syndrome (DS; hereafter referred to as DS mice), were generated by targeted deletion of the last exon, encoding domain IV from the S3-S6 segment and the entire C-terminal tail of Na V 1.1 channel, as previously described (Yu et al., 2006).”
InfluentialSelf-citationMacdonald, R. L., & Gallagher, M. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00084-x · Cited by 5
Büren, C., Kamp, M. A., Munoz‐Bendix, C., Steiger, H., Windolf, J., & Dibué, M. (2017) · Epilepsy & Behavior Case Reports · doi:10.1016/j.ebcr.2017.12.003 · Cited by 4
“Increased excitability due to loss of function from mutations of SCN1A may reflect compensatory upregulation of other VGSC and voltage-gated calcium channels [33] or lack of signaling through GABA-ergic [inhibitory] interneurons in the hippocampus [34].”
BackgroundScn1a and Cacna1a mutations mutually alter their original phenotypes in rats
Ohmori, I., Kobayashi, K., & Ouchida, M. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104859 · Cited by 4
A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
Das, A., Smith, M. A., & O’Dowd, D. K. (2021) · Journal of Visualized Experiments · doi:10.3791/62846 · Cited by 5
Gene Interactions and Modifiers in Epilepsy
Meisler, M. H., & O’Brien, J. E. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0059 · Cited by 4
Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11
Kearney, J. A., Copeland-Hardin, L., Duarte, S., Zachwieja, N. J., Eckart-Frank, I. K., & Hawkins, N. A. (2022) · Mammalian Genome · doi:10.1007/s00335-022-09955-y · Cited by 4
Developmental changes in brain activity of heterozygous Scn1a knockout rats
Tahara, M., Higurashi, N., Hata, J., Nishikawa, M., Ito, K. R., Hirose, S., Kaneko, T., Mashimo, T., Sakuma, T., Yamamoto, T., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1125089 · Cited by 4
“1 haploinsufficiency in these neurons is considered the major mechanism underlying DS epilepsy (7, 9, 10).”
BackgroundKnierim, E., Vogt, J., Kintscher, M., Ponomarenko, A. A., Baumgart, J., Beed, P. S., Korotkova, T. M., Trimbuch, T., Panzer, A., Steinlein, O. K., et al. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad051 · Cited by 4
Forcelli, P. A., & Gale, K. (2014) · InTech eBooks · doi:10.5772/58584 · Cited by 4
Jones, D. L., & McNamara, J. O. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00040-7 · Cited by 4
The More, the Better: Modeling Dravet Syndrome with Induced Pluripotent Stem Cell-Derived Neurons
Kearney, J. A. (2014) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7597-14.1.33 · Cited by 4
Mechanisms of genetic epilepsies
Hedrich, U. B. S., Maljevic, S., & Lerche, H. (2013) · e-Neuroforum · doi:10.1007/s13295-013-0040-6 · Cited by 5
The case for realistic modeling in understanding seizures
Thomas, E. A., & Petrou, S. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.12.1771 · Cited by 4
Interneuron Loss as a Cause of Seizures: Lessons from Interneuron-Deficient Mice
Jones, D. M., Calcagnotto, M. E., & Sebe, J. Y. (2009) · Neuromethods · doi:10.1007/978-1-60327-263-6_8 · Cited by 4
Novel SCN1A variants in Dravet syndrome and evaluating a wide approach of patient selection
Surovy, M., Šoltýsová, A., Kolníková, M., Sýkora, P., Ilenčíková, D., Ficek, A., Radvánszky, J., & Kádaši, Ľ. (2016) · General Physiology and Biophysics · doi:10.4149/gpb_2016002 · Cited by 4
Canaux sodiques et canalopathies : douleurs neuropathiques, épilepsies, migraine
Cestèle, S., & Mantegazza, M. (2016) · Douleur et Analgésie · doi:10.1007/s11724-016-0478-8 · Cited by 4
Self-citationMechanisms of Antiepileptic Drug Action
Simeone, T. A. (2010) · Epilepsy · doi:10.1201/9781420085594-c8 · Cited by 5
Molecular Genetics of Dravet Syndrome
Weckhuysen, S., Suls, A., & Jonghe, P. D. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0023846 · Cited by 4
Lessons from Familial Hemiplegic Migraine and Cortical Spreading Depression
Pietrobon, D. (2017) · Wiley eBooks · doi:10.1002/9781118967225.ch15 · Cited by 4
Early hippocampal hyperexcitability followed by disinhibition in a mouse model of Dravet syndromePreprint
Almog, Y., Brusel, M., Anderson, K., & Rubinstein, M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/790170 · Cited by 4
“Together, these data confirm that DS mice carrying the Scn1aA1783V missense mutation recapitulate Dravet epilepsy similarly to earlier DS models which are based on Scn1a truncation mutations (Ogiwara et al., 2007; Yu et al., 2006).”
BackgroundResultInfluentialOlkhova, E. A., Smith, L. A., Dennis, B. H., Ng, Y. S., LeBeau, F. E. N., & Gorman, G. S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230191 · Cited by 3
Sex differences in seizure presentation in a Dravet syndrome mouse model
Vermudez, S. A. D., Lin, R., McGinty, G. E., Choe, Y., Liebhardt, A., Hui, B., Lubbers, E., Dhamne, S. C., Hameed, M. Q., & Rotenberg, A. (2025) · Neuroreport · doi:10.1097/wnr.0000000000002159 · Cited by 3
Gallucci, A., Potet, F., Santos, S., Lin, Z., Theile, J. W., Yoger, K., Ren, W., Wang, L., Lebreton, S., Attinost, I., et al. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100072 · Cited by 3
Dravet syndrome therapeutics: where are we, what works, and what’s next?
Bagchi, V. A., Ziobro, J. M., & Isom, L. L. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2576608 · Cited by 3
“Landmark studies in the 2000s established the influential ‘interneuron hypothesis,’ demonstrating selective impairment of sodium current density and action potentials specifically in parvalbumin-positive (PV+) GABAergic inter-neurons [20,27].”
Kruth, K., Kasuya, J., Hand, V., Iyengar, A. S. R., & Kitamoto, T. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04673-2 · Cited by 3
“SCN1A is predominantly expressed in GAB-Aergic inhibitory interneurons, and its impairment results in disinhibition of excitatory circuits, enhancing neuronal excitability and promoting the synchronized firing that characterizes seizures [16].”
Engineering a human-based translational activator for targeted protein expression restoration
Sinnott, R. W., Solanki, A., Govind, A. P., Green, W. N., & Dickinson, B. C. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag113 · Cited by 3
“Previous work in DS mouse models characterized GABAergic inhibitory interneurons in the hippocampus and cortex as a crucial cell type impaired by reduced Na V 1.1 expression and a key driver of the epileptic phenotype [ 60 ].”
InfluentialGhovanloo, M., & Waxman, S. G. (2026) · The Journal of Physiology · doi:10.1113/jp290383 · Cited by 4
“3 are primarily expressed in inhibitory GABAergic neurons (Lamar et al., 2017; Whitaker et al., 2001; Yu et al., 2006).”
Targeted Resequencing of Epilepsy Genes: A Pharmaco-Therapeutic Perspective
Romanelli, A. M. P. (2014) · International Journal of Neurorehabilitation · doi:10.4172/2376-0281.1000116 · Cited by 3
“1 (SCN1A) are a common cause of dominantly inherited and sporadic epilepsy, several knockout, knockin or transgenic mouse models with null or missense mutations of this gene have been generated to produce distinct seizure phenotypes [59,60].”
BackgroundKoh, B., Kim, Y. E., Park, S. B., Kim, S. S., Lee, J., Jo, J. H., Lee, K. J., Bae, D. H., Kim, T., Cho, S., et al. (2024) · ACS Omega · doi:10.1021/acsomega.4c05039 · Cited by 6
Farahani, N. I., Lin, L. D., Nazir, S., Naderi, A., Rokos, L., McIntosh, A. R., & Julian, L. M. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1478572 · Cited by 4
Current Trends in Dravet syndrome Research
Higurashi, N. (2013) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000152 · Cited by 4
Sodium Channelopathies of the Central Nervous System
DeCaen, P. G., George, A. L., & Thompson, C. H. (2019) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190669164.013.21 · Cited by 3
Hernández, A. V. M., Caro‐Llopis, A., Rubio-Sanchez, P., Martínez, J. C., Vila, M. T., Monfort, S., & Martínez, F. (2022) · Journal of Child Neurology · doi:10.1177/08830738211072694 · Cited by 4
Joseph, D. J., von Deimling, M., Risbud, R. M., McCoy, A. J., & Marsh, E. D. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2024.05.020 · Cited by 5
Advances in Design and Development of Sodium Channel Blockers
Zuliani, V., Amori, L., & Rivara, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-19922-6_4 · Cited by 3
Personalized treatment in the epilepsies: challenges and opportunities
Balestrini, S., & Sisodiya, S. M. (2018) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2018.1486189 · Cited by 5
Garrison, C. E., Guan, W., Kato, M., Tamsett, T. J., Patel, T., Sun, Y., & Pathak, T. P. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00415 · Cited by 3
Rosch, R. E., & Goldberg, E. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89932-1.00015-9 · Cited by 4
In silico prediction and in vivo testing of promoters targeting GABAergic inhibitory neurons
Niibori, Y., Duba-Kiss, R., Bruder, J. T., Smith, J. B., & Hampson, D. R. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.01.007 · Cited by 7
Ho, S., Chen, I., Tsai, C., Chang, K., Lin, C., Chern, Y., & Liou, H. (2023) · Hippocampus · doi:10.1002/hipo.23584 · Cited by 4
“Impairment of parvalbumin-expressing (PV + ) GABAergic interneuron synaptic transmission is a common pathological mechanism in DS mouse models (Ogiwara et al., 2007; Tsai et al., 2015; Yu et al., 2006).”
BackgroundGene interactions and modifiers in epilepsy
Meisler, M. H. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02852.x · Cited by 3
Epilepsy and Disease Modification:Animal Models for Novel Drug Discovery
White, H. S. (2010) · Epilepsy · doi:10.1201/9781420085594-c9 · Cited by 3
Expecting the Unexpected: Lack of in Vivo Network Defects in an Scn1a Model of Dravet Syndrome
Hull, J. M., & Isom, L. L. (2016) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-16.6.408 · Cited by 3
The voltage-gated channelopathies as a paradigm for studying epilepsy-causing genes
Carpenter, J. C., & Schorge, S. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.01.004 · Cited by 3
Berg, A. T. (2010) · Springer eBooks · doi:10.1007/978-1-84882-128-6_2 · Cited by 3
Voltage‐Gated Sodium Channels in Peripheral Nociceptive Neurons as Targets for the Treatment of Pain
Cummins, T. (2009) · Wiley eBooks · doi:10.1002/9780470522226.ch3 · Cited by 3
Understanding and treating a channelopathy: Severe myoclonic epilepsy of infancy
Krauss, G. L., & Morrison, P. F. (2007) · Neurology · doi:10.1212/01.wnl.0000271091.01436.35 · Cited by 3
Genetic Modifiers of Neurological Disease
Kearney, J. A., & Jorge, B. S. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0023856 · Cited by 3
AVANZINI, G., & Franceschetti, S. (2015) · Wiley eBooks · doi:10.1002/9781118936979.ch3 · Cited by 3
Weerdmeester, L., Schleimer, J., & Schreiber, S. (2025) · eLife · doi:10.7554/elife.103781 · Cited by 3
GENETICS | Single Gene Mutations in Inherited and Sporadic Epilepsy
Kearney, J. A., & Meisler, M. H. (2009) · Elsevier eBooks · doi:10.1016/b978-012373961-2.00127-2 · Cited by 3
Frazee, A., Zybura, A., & Cummins, T. (2025) · Cells · doi:10.3390/cells14040291 · Cited by 2
“1 have been implicated in various disease phenotypes, including epilepsy and familial hemiplegic migraine 3 (FHM3) [1–3 ,6– 10 ].”
Emerging Genetic Therapies in Epilepsy
Sullivan, J. E., & Hood, V. L. (2025) · Seminars in Neurology · doi:10.1055/a-2544-1530 · Cited by 3
“5,10,11 19 Despite the identi fi cation of molecular and cellular targets for a genetic-based therapy, some technical challenges remained: the large size of the gene and effective delivery to the appropriate cells in the CNS.”
Scalise, S., Gaeta, A., Aprigliano, E., Lucchino, V., Covello, R., Talarico, M., Puccio, B., Guzzi, P. H., Veltri, P., Gambardella, A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-09208-3 · Cited by 2
“I), consistent with the known disruption of GABAergic inhibition in SCN1A loss-of-function mutations 17,18 .”
Depolarization block induction via slow NaV1.1 inactivation in Dravet syndrome
Lemaire, L., Desroches, M., Rodrigues, S., & Campillo, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-17468-2 · Cited by 2
“This case has been less studied than that of truncating mutations 43 , for which mouse models have been available for nearly two decades 35,36 .”
Fletcher, E. V., Shard, C., Boyle, Y., Milligan, C. J., Cross, R. S., Jones, A. C., Francis, A., Dewdney, B., Barker, M., Rezaeiravesh, S., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-15319-x · Cited by 2
Cestèle, S., Harper, A. J., Marra, S., Leroudier, N., Rusconi, R., Dhifallah, S., Horrocks, I. A., Kirkham, F. J., Morgan, I. M. R., Singh, J., et al. (2026) · Neurology Genetics · doi:10.1212/nxg.0000000000200352 · Cited by 2
Self-citationPhilliben, R., Willis, E., McManus, O. K., Holder, D. L., Policherla, J., & Espinoza, A. C. (2026) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2026.04.018 · Cited by 2
Prime editing of a pathogenic Scn1a allele ameliorates seizure phenotypes in a GEFS + mouse model
Kissling, L., Pietrafesa, F., Ranucci, M., Böck, D., Mathis, N., Kulcsár, P. I., Ioannidi, E. I., Schmidheini, L., Tálas, A., Villiger, E. A., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adz2557 · Cited by 4
In vivo adenine base editing ameliorates Dravet syndrome phenotypes in a mouse model
Nelson, A. T., Hill, S. F., Simon, M., Clatot, J., Sakai, H. A., Xie, J., Sousa, A. A., An, M., Gao, G., Lutz, C. M., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adx5999 · Cited by 4
Makridis, K. L., Laux, L., & Kaindl, A. M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1809113 · Cited by 2
“1 function predominantly in inhibitory interneurons, leading to reduced interneuron sodium current, impaired inhibition, and network hyperexcitability (Yu et al., 2006).”
Higurashi, N., Okano, H., & Hirose, S. (2013) · Future Neurology · doi:10.2217/fnl.13.34 · Cited by 3
Dravets syndrom som årsak til epilepsi og utviklingshemning
Lund, C., Bremer, A., Lossius, M. I., Selmer, K. K., Brodtkorb, E., & Nakken, K. O. (2012) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.11.0539 · Cited by 3
The Genetic Facets of Dravet Syndrome: Recent Insights
Mouhi, H. E., Abbassi, M., Jalte, M., Natiq, A., Bouguenouch, L., & Chaouki, S. (2024) · Annals of Child Neurology · doi:10.26815/acn.2023.00367 · Cited by 4
Abnormalities in the functional activity of neural networks in a human iPSC model of Dravet syndrome
Mzezewa, R., Hyvärinen, T., Kulta, O., Vinogradov, A., Pesu, E., Isosaari, L., Vuolanto, V., Kapucu, F. E., Schuster, J., Dahl, N., et al. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104958 · Cited by 4
Fever-induced seizures: where are we today?
Referentni centar Ministarstva zdravstva za epilepsiju i konvulzivne bolesti razvojne dobi, Z. Z. D. N. I. D. P., Nišević, J. R., Prpić, I., Referentni centar Ministarstva zdravstva za epilepsiju i konvulzivne bolesti razvojne dobi, Z. Z. D. N. I. D. P., Kolić, I., & Referentni centar Ministarstva zdravstva za epilepsiju i konvulzivne bolesti razvojne dobi, Z. Z. D. N. I. D. P. (2016) · Medicina · doi:10.21860/medflum2016_4ramr · Cited by 2
Epilepsy-Specific Citation Classics Revisited
Kellogg, M. A., Westbrook, G. L., & Spencer, D. C. (2018) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7597.18.2.72 · Cited by 2
De novo truncating mutation in SCN1A as a cause of febrile seizures plus (FS+)
Jaimes, A., Guerrero, R., Giráldez, B. G., & Serratosa, J. M. (2020) · Epileptic Disorders · doi:10.1684/epd.2020.1167 · Cited by 2
Experimental models of febrile seizures and febrile status epilepticus
Chen, K. D., Curran, M. M., & Baram, T. Z. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89932-1.00013-5 · Cited by 2
Circuit-selective cell-autonomous regulation of inhibition in pyramidal neurons by Ste20-like kinase
Royero, P., Quatraccioni, A., Fruengel, R., Silva, M. H., Bast, A., Ulas, T., Beyer, M., Opitz, T., Schultze, J. L., Graham, M. E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111757 · Cited by 3
What Rodent Models Teach Us about the Association of Autism and Epilepsy
Golshani, P. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197549469.003.0059 · Cited by 3
Homeostatic regulation of a motor circuit through temperature sensing rather than activity sensing
Cannon, D., & Santin, J. M. (2025) · Current Biology · doi:10.1016/j.cub.2025.03.054 · Cited by 3
Metadata
- Authors
- Yu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A.
- Affiliations
- University of Washington (US)
- Corresponding author
- Catterall, William A
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-08-20
- Volume
- 9
- Issue
- 9
- Pages
- 1142-1149
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2105423985
- Cited by
- 1,173
- References
- 55
- Citations by year
- 2026: 54 · 2025: 72 · 2024: 66 · 2023: 69 · 2022: 73 · 2021: 85 · 2020: 70 · 2019: 70 · 2018: 53 · 2017: 59 · 2016: 47 · 2015: 63 · 2014: 64 · 2013: 64 · 2012: 52
- FWCI
- 22.30
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-01-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- Dravet syndrome, SCN1A, Nav1.3, GABAergic interneurons, sodium current, hippocampus, neuronal hyperexcitability, epilepsy, genetic background effects
- MeSH terms
- Action Potentials, Animals, Cell Line, Disease Models, Animal, Electroencephalography, Epilepsies, Myoclonic, gamma-Aminobutyric Acid, Genotype, Humans, Infant, Interneurons, Mice, Inbred C57BL, Mice, Inbred Strains, Mutation, Nerve Tissue Proteins, Phenotype, Seizures, Immunoblotting, Sodium Channels, Survival Rate, Mice, Knockout, Patch-Clamp Techniques, Mice, NAV1.1 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.